162 related articles for article (PubMed ID: 36246008)
1. Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Mackey DA; Constable IJ; De Roach JN; Chen FK
Ophthalmol Sci; 2021 Mar; 1(1):100005. PubMed ID: 36246008
[TBL] [Abstract][Full Text] [Related]
2. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
[TBL] [Abstract][Full Text] [Related]
3. CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.
Heath Jeffery RC; Thompson JA; Lamey TM; McLaren TL; McAllister IL; Constable IJ; Mackey DA; De Roach JN; Chen FK
Retina; 2021 Dec; 41(12):2578-2588. PubMed ID: 34125082
[TBL] [Abstract][Full Text] [Related]
4. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
[TBL] [Abstract][Full Text] [Related]
5. Factors Influencing Retinal Pigment Epithelium-Atrophy Progression Rate in Stargardt Disease.
Cicinelli MV; Rabiolo A; Brambati M; Viganò C; Bandello F; Battaglia Parodi M
Transl Vis Sci Technol; 2020 Jun; 9(7):33. PubMed ID: 32832238
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
[TBL] [Abstract][Full Text] [Related]
9. Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.
Kong X; West SK; Strauss RW; Munoz B; Cideciyan AV; Michaelides M; Ho A; Ahmed M; Schönbach EM; Cheetham JK; Ervin AM; Scholl HPN;
Ophthalmol Retina; 2017; 1(6):514-523. PubMed ID: 31047445
[TBL] [Abstract][Full Text] [Related]
10. Genotype-Specific Lesion Growth Rates in Stargardt Disease.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Constable IJ; De Roach JN; Chen FK
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946930
[TBL] [Abstract][Full Text] [Related]
11. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
[TBL] [Abstract][Full Text] [Related]
12. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
[TBL] [Abstract][Full Text] [Related]
13. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17).
Strauss RW; Ho A; Jha A; Fujinami K; Michaelides M; Cideciyan AV; Audo I; Birch DG; Sadda S; Ip M; West S; Schönbach EM; Kong X; Scholl HPN;
Am J Ophthalmol; 2023 Jun; 250():157-170. PubMed ID: 36764427
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic characteristics of late-onset Stargardt's disease.
Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
[TBL] [Abstract][Full Text] [Related]
15. Association Between Genotype and Phenotype Severity in ABCA4-Associated Retinopathy.
Bianco L; Arrigo A; Antropoli A; Manitto MP; Martina E; Aragona E; Bandello F; Battaglia Parodi M
JAMA Ophthalmol; 2023 Sep; 141(9):826-833. PubMed ID: 37498587
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Green Versus Blue Fundus Autofluorescence in
Müller PL; Pfau M; Mauschitz MM; Möller PT; Birtel J; Chang P; Gliem M; Schmitz-Valckenberg S; Fleckenstein M; Holz FG; Herrmann P
Transl Vis Sci Technol; 2018 Sep; 7(5):13. PubMed ID: 30279998
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of ultra-widefield fundus autofluorescence.
Xu A; Chen C
Int Ophthalmol; 2021 Feb; 41(2):727-741. PubMed ID: 33040254
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Retinal Involvement in Extensive Macular Atrophy with Pseudodrusen-Like Deposits.
Battaglia Parodi M; Antropoli A; Bianco L; Arrigo A; Pili L; Saladino A; Bandello F
Ophthalmol Retina; 2023 Oct; 7(10):910-917. PubMed ID: 37423485
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment.
Kuehlewein L; Dustin L; Sagong M; Hariri A; Mendes TS; Rofagha S; Bhisitkul RB; Sadda SR
Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):224-31. PubMed ID: 26985795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
